1031417-73-8 Usage
Description
1H-Indazole-5-carboxylic acid, 3-chlorois a chemical compound with the molecular formula C9H5ClN2O2. It belongs to the class of indazole carboxylic acids and contains a chloro group at the third position on the indazole ring. 1H-Indazole-5-carboxylic acid, 3-chlorohas potential applications in the pharmaceutical industry as a building block for the synthesis of various pharmaceuticals and biologically active compounds. Its unique structure and reactivity make it a promising candidate for drug development and medicinal chemistry research. Additionally, it may also have use in the field of organic synthesis for the preparation of diverse chemical compounds.
Uses
Used in Pharmaceutical Industry:
1H-Indazole-5-carboxylic acid, 3-chlorois used as a building block for the synthesis of various pharmaceuticals and biologically active compounds. Its unique structure and reactivity make it a promising candidate for drug development and medicinal chemistry research.
Used in Organic Synthesis:
1H-Indazole-5-carboxylic acid, 3-chlorois used in the field of organic synthesis for the preparation of diverse chemical compounds. Its chloro group at the third position on the indazole ring provides opportunities for further functionalization and the creation of new molecules with potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1031417-73-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,1,4,1 and 7 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1031417-73:
(9*1)+(8*0)+(7*3)+(6*1)+(5*4)+(4*1)+(3*7)+(2*7)+(1*3)=98
98 % 10 = 8
So 1031417-73-8 is a valid CAS Registry Number.
1031417-73-8Relevant articles and documents
PGDH INHIBITORS AND METHODS OF MAKING AND USING
-
Paragraph 0271; 0278; 0283; 0695; 0697, (2021/07/31)
Disclosed herein are compounds that can inhibit 15-hydroxyprostaglandin dehydrogenase. Such compounds may be administered to subjects that may benefit from modulation of prostaglandin levels.
